Commentary. Lysosomotropic agents.
D000900:Anti-Bacterial Agents / Q000378:metabolism; D000906:Antibodies; D001424:Bacterial Infections / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism; D002738:Chloroquine / Q000494:pharmacology; D004247:DNA / Q000378:metabolism; D003911:Dextrans / Q000378:metabolism; D004705:Endocytosis; D004798:Enzymes / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008081:Liposomes / Q000378:metabolism; D008099:Liver / Q000166:cytology; D008247:Lysosomes / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D008566:Membranes / Q000187:drug effects; D008661:Metabolism, Inborn Errors / Q000378:metabolism; D010272:Parasitic Diseases / Q000378:metabolism; D010539:Permeability; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D011134:Polysaccharides / Q000378:metabolism; D011205:Povidone / Q000378:metabolism; D013307:Streptomycin / Q000494:pharmacology; D013501:Surface-Active Agents / Q000378:metabolism; D013997:Time Factors; D014343:Trypan Blue / Q000378:metabolism; D014777:Virus Diseases / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000906:Antibodies; D002352:Carrier Proteins; D003911:Dextrans; D004798:Enzymes; D008081:Liposomes; D004364:Pharmaceutical Preparations; D011134:Polysaccharides; D013501:Surface-Active Agents; D002738:Chloroquine; D004247:DNA; D011205:Povidone; D014343:Trypan Blue; D013307:Streptomycin